0000899866-15-000028.txt : 20150209 0000899866-15-000028.hdr.sgml : 20150209 20150209204632 ACCESSION NUMBER: 0000899866-15-000028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150205 FILED AS OF DATE: 20150209 DATE AS OF CHANGE: 20150209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BELL LEONARD CENTRAL INDEX KEY: 0001231949 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 15590192 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 4 1 wf-form4_142353278262478.xml FORM 4 X0306 4 2015-02-05 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001231949 BELL LEONARD C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE CT 06410 1 1 0 0 CEO Common Stock, par value $.0001 per share 2015-02-05 4 A 0 33990 0 A 958708 D Common Stock, par value $.0001 per share 2015-02-09 4 S 0 8660 173.98 D 950048 D On February 5, 2015, the Compensation Committee determined that the reporting person earned 33,990 Performance Share Units upon achievement of certain performance targets previously established by the Compensation Committee. 1/3 of such shares vested on February 5, 2015 and 1/3 vest on each subsequent anniversary. This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $173.87 - $174.33. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. /s/ Michael Greco, Attorney-in-Fact for Leonard Bell 2015-02-09